Quantcast

Health Care Sector Update for 08/16/2017: PSTI,IDXG,JAGX


Shutterstock photo

Top Health Care Stocks

JNJ +0.57%

PFE -0.18%

ABT +1.60%

MRK +0.08%

AMGN +0.94%

Health care stocks were moderating somewhat during afternoon trading, with the NYSE Health Care Index posting a nearly 0.2% gain while shares of health care companies in the S&P 500 also were up almost 0.2% as a group.

In company news, Pluristem Therapeutics ( PSTI ) advanced on Wednesday, climbing over 12% to a session high of $1.27 a share after the Pentagon today signed off on a pilot study of the biotech company's PLX-R18 cell therapy as a potential treatment either before or within the first 24 hours after severe radiation exposure.

The U.S. Department of Defense-authorized study will be performed by Armed Forces Radiobiology Research Institute, part of the Uniformed Services University of Health Sciences.

In other sector news,

(+) IDXG, (+33.8%) UnitedHealthcare ( UNH ), through its Oxford Health Plans division, will cover the cost of the company's ThyraMIR test for indeterminate thyroid nodules, retroactive to Aug. 1.

(-) FATE, (-0.6%) Files $100 mln, mixed-securities registration statement with U.S. regulators, also saying a shareholder may sell up to 1 mln shares as part of the same offering. Also receives U.S. patent covering the use of prostaglandins for viral transduction enhancement.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.



This article appears in: Investing , US Markets
Referenced Symbols: PSTI , UNH , IDXG , JAGX



More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities










Research Brokers before you trade

Want to trade FX?